EUVIMEDEUVIMED entdecken
Crossref

Insulin Pump-Associated Adverse Events: A Qualitative Descriptive Study of Clinical Consequences and Potential Root Causes

Jamie L Estock iD, Ronald A Codario, Shimrit Keddem, Margaret F Zupa, Keri L Rodriguez iD, Monica M DiNardo

Diabetes Technology & Therapeutics · 2023

DOI: 10.1089/dia.2022.0498 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes Technology & Therapeutics, 2023. Verfasst von Jamie L Estock und 5 weiteren Autor:innen. Beteiligte Einrichtung: Office of Research and Development; Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Hypoglycemia, Hyperglycemia, Diabetes Mellitus, Type 1. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To explore the clinical consequences and potential root causes of insulin pump-associated adverse events (AEs) reported in the Food and Drug Administration's Manufacturer and User Facility Device Experience (MAUDE) database. Research Design and Methods: Qualitative template analysis of narrative data in a 20% stratified random sample (n = 2429) of reported AEs that occurred during the first 6 months of 2020 involving five insulin pump models marketed at that time: (1) MiniMed™ 670G, (2) MiniMed™ 630G, (3) Omnipod®, (4) Omnipod DASH®, and (5) t:slim X2™.

Results

Of the 2429 AEs, 92% included a clinical consequence in the narrative description, with critical hyperglycemia (i.e., blood glucose [BG] >400 mg/dL; 47%) and critical hypoglycemia (i.e., BG

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypoglycemiaHyperglycemiaDiabetes Mellitus, Type 1HumansInsulinBlood GlucoseInsulin Infusion SystemsHypoglycemic Agents

Stichwörter der Autor:innen

Diabetes device safetyInsulin pumpInsulin pump adverse eventsInsulin pump injuriesInsulin pump safety

Substanzen

InsulinBlood GlucoseHypoglycemic Agents

Autor:innen und Institutionen

  • Office of Research and Development; Pittsburgh, Pennsylvania, USA.
  • Center for Health Equity Research and Promotion; Pittsburgh, Pennsylvania, USA.
  • Department of Endocrinology; VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, USA.
  • Division of Endocrinology & Metabolism, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  • Center for Health Equity Research and Promotion, Corporal Michael J. Crescenz VA Medical Center, Philadelphia, Pennsylvania, USA.
  • Department of Family Medicine & Community Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

ORCID-Profile: Jamie L Estock, Keri L Rodriguez

Zitieren

APA

Estock, J. L., Codario, R. A., Keddem, S., Zupa, M. F., Rodriguez, K. L., & DiNardo, M. M. (2023). Insulin Pump-Associated Adverse Events: A Qualitative Descriptive Study of Clinical Consequences and Potential Root Causes. Diabetes Technology & Therapeutics. https://doi.org/10.1089/dia.2022.0498

Vancouver

Estock JL, Codario RA, Keddem S, Zupa MF, Rodriguez KL, DiNardo MM. Insulin Pump-Associated Adverse Events: A Qualitative Descriptive Study of Clinical Consequences and Potential Root Causes. Diabetes Technology & Therapeutics. 2023. doi:10.1089/dia.2022.0498

BibTeX
@article{Estock2023,
  author = {Estock, Jamie L and Codario, Ronald A and Keddem, Shimrit and Zupa, Margaret F and Rodriguez, Keri L and DiNardo, Monica M},
  title = {Insulin Pump-Associated Adverse Events: A Qualitative Descriptive Study of Clinical Consequences and Potential Root Causes},
  journal = {Diabetes Technology & Therapeutics},
  year = {2023},
  doi = {10.1089/dia.2022.0498}
}
Kostenlos starten →